Atlas FDA

EMBLEM (Subcutaneous ICD Devices)

FDA premarket approval P110042/S119 · decided 2019-02-22

Approval details

PMA number
P110042
Supplement
S119
Supplement type
Real-Time Process
Supplement reason
Change Design/Components/Specifications/Material
Trade name
EMBLEM (Subcutaneous ICD Devices)
Generic name
Implantable cardioverter defibrillator (non-CRT)
Applicant
Boston Scientific Corporation
Date received
2018-12-03
Decision date
2019-02-22
Days to decision
81 days
Decision code
APPR
Product code
LWS
Advisory committee
Cardiovascular
Expedited review
No
Location
St Paul, MN
Statement
Approval for changes to the Server and Communicator software updates necessary for LATITUDE NXT Release.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
TheraSphere 360™ Y-90 Management Platform (K262462)Boston Scientific Corporation2026-07-24
FARADRIVE™ Steerable Sheath (M004PF21M402) (K262165)Boston Scientific Corporation2026-07-24
OBSIDIO Conformable Embolic (K261488)Boston Scientific Corporation2026-07-24
WallFlex Esophageal Stent System;Agile Esophageal Over-the-Wire (OTW) Stent System (K261978)Boston Scientific Corporation2026-07-10
RIVOS™ EUS Access Device (M00553900) (K260428)Boston Scientific Corporation2026-06-17
MOSES Raydar™ (K260100)Boston Scientific Corporation2026-05-18
TruSelect™ 2.6 Microcatheter (K260771)Boston Scientific Corporation2026-05-15
Asurys Fluid Management System (K251273)Boston Scientific Corporation2026-03-27